Thermo Fisher Scientific Inc. (TMO) Return on Equity (ROE): 13.21%
Is Thermo Fisher Scientific Inc.’s return on equity (ROE) high or low?
Thermo Fisher Scientific Inc.'s return on equity (ROE) of 13.21% is 13% below its 5-year average of 15.24%, near the low end of its 5-year range (12.61%–18.94%).
As of Wednesday, June 17, 2026. 4.06% above its 12-month average of 12.70%.
TMO Return on Equity (ROE) Chart
TMO Average Return on Equity (ROE) Chart
TMO Current vs Average Return on Equity (ROE) Chart
TMO Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
13.21%
RETURN ON EQUITY (ROE) AVG TTM
12.70%
RETURN ON EQUITY (ROE) AVG 3Y
13.51%
RETURN ON EQUITY (ROE) AVG 5Y
15.24%
RETURN ON EQUITY (ROE) AVG 10Y
12.90%
RETURN ON EQUITY (ROE) AVG 15Y
10.86%
RETURN ON EQUITY (ROE) AVG 20Y
9.93%
CURRENT VS TTM AVG
+4.06%
CURRENT VS 3Y AVG
-2.18%
CURRENT VS 5Y AVG
-13.31%
CURRENT VS 10Y AVG
+2.38%
CURRENT VS 15Y AVG
+21.59%
CURRENT VS 20Y AVG
+33.04%
TMO Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $175.64B | 13.21% | 12.70% | 13.51% | 15.24% |
| Amgen Inc. (AMGN)vs › | $187.59B | 84.87% | 79.33% | 111.35% | 101.76% |
| Gilead Sciences, Inc. (GILD)vs › | $158.06B | 39.19% | 19.98% | 21.60% | 19.44% |
| Abbott Laboratories (ABT)vs › | $157.84B | 12.06% | 20.32% | 18.59% | 17.97% |
| Novo Nordisk A/S (NVO)vs › | $193.53B | 60.74% | 61.58% | 67.05% | 123.42% |
| Pfizer Inc. (PFE)vs › | $148.41B | 8.31% | 9.04% | 13.32% | 16.07% |
| Intuitive Surgical, Inc. (ISRG)vs › | $145.70B | 17.05% | 15.07% | 13.91% | 13.46% |
| Danaher Corporation (DHR)vs › | $128.06B | 6.97% | 7.38% | 9.51% | 10.24% |
| CVS Health Corporation (CVS)vs › | $127.73B | 3.79% | 4.23% | 6.35% | 7.74% |
| Stryker Corporation (SYK)vs › | $119.06B | 14.52% | 14.50% | 15.05% | 14.30% |
Return Analysis
ROE
13.2%
ROA
6.0%
Thermo Fisher Scientific Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The return on equity (ROE) for TMO stock is 13.21%.
- Is Thermo Fisher Scientific Inc.'s return on equity (ROE) high or low?
- Thermo Fisher Scientific Inc.'s return on equity (ROE) of 13.21% is 13% below its 5-year average of 15.24%, near the low end of its 5-year range (12.61%–18.94%).
- What is the TTM average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average return on equity (ROE) for TMO stock is 12.70%.
- What is the 3Y average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average return on equity (ROE) for TMO stock is 13.51%.
- What is the 5Y average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average return on equity (ROE) for TMO stock is 15.24%.
- What is the 10Y average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average return on equity (ROE) for TMO stock is 12.90%.
- What is the 15Y average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average return on equity (ROE) for TMO stock is 10.86%.
- What is the 20Y average return on equity (ROE) for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average return on equity (ROE) for TMO stock is 9.93%.
Thermo Fisher Scientific Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 12.61% |
| 2024-12-31 | 12.78% |
| 2023-12-31 | 12.83% |
| 2022-12-31 | 15.80% |
| 2021-12-31 | 18.94% |
| 2020-12-31 | 18.47% |
| 2019-12-31 | 12.45% |
| 2018-12-31 | 10.65% |
| 2017-12-31 | 8.76% |
| 2016-12-31 | 9.39% |
| 2015-12-31 | 9.25% |
| 2014-12-31 | 9.22% |
| 2013-12-31 | 7.55% |
| 2012-12-31 | 7.62% |
| 2011-12-31 | 8.84% |
| 2010-12-31 | 6.74% |
| 2009-12-31 | 5.51% |
| 2008-12-31 | 6.66% |
| 2007-12-31 | 5.25% |
| 2006-12-31 | 1.21% |
| 2005-12-31 | 7.99% |
| 2004-12-31 | 13.57% |
| 2003-12-31 | 8.39% |
| 2002-12-31 | 15.23% |
| 2001-12-31 | -0.04% |
| 2000-12-31 | -1.43% |
| 1999-12-31 | -8.67% |
| 1998-12-31 | 8.09% |
| 1997-12-31 | 11.98% |
| 1996-12-31 | 10.88% |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper